Posted On: 07/25/2016 8:52:39 PM
Post# of 72446
Sox,
It seems CTIX wanted a POC started on Hidradenitis Suppurative sometime in 2016.
Why would they not start a POC on atopical dermatitis (type of ezcema) knowing that Anacor Pharmaceuticals was bought out by Pfizer for 5.2 billion mainly for their topical ezcema ointment known as Crisaborole.
Does proving Brilacidin works on Hidradenitis Suppurative mean a likely success for atopical dermatitis since HS looks difficult to treat?
I wanted to email Leo about this, but my response rate is probably not nearly as good as yours.
It seems CTIX wanted a POC started on Hidradenitis Suppurative sometime in 2016.
Why would they not start a POC on atopical dermatitis (type of ezcema) knowing that Anacor Pharmaceuticals was bought out by Pfizer for 5.2 billion mainly for their topical ezcema ointment known as Crisaborole.
Does proving Brilacidin works on Hidradenitis Suppurative mean a likely success for atopical dermatitis since HS looks difficult to treat?
I wanted to email Leo about this, but my response rate is probably not nearly as good as yours.
(0)
(0)
